APOC2 and hypertriglyceridemia: This result is similar to the treatment of APOC2-deficient patients with severe hypertriglyceridemia in which transfusions of normal, APOC2-containing plasma leads to rapid (within 1 day) reductions in plasma TGs (Breckenridge et al., 1978).